国内2018高清视频,国产高清视频色拍

您好，歡迎來到拜力生物網(wǎng)站！請(qǐng)登錄注冊(cè)

我的訂單 | 聯(lián)系我們 | 在線客服QQ：3012681483 | 客服電話：400-968-7988 | 工作時(shí)間：08:30-17:30

主營產(chǎn)品： ELISA試劑盒、抗體、補(bǔ)體血清、兔補(bǔ)體、干擾素、小鼠測(cè)溫儀、進(jìn)口試劑、Quidel代理、Swant代理、PBL Assay Science代理

網(wǎng)站首頁產(chǎn)品中心代理品牌新聞資訊資源中心關(guān)于我們

所在位置：首頁 > 產(chǎn)品中心 > AGScientific > AGScientific產(chǎn)品

訂購信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

VX-702

品牌：AG Scientific

貨號(hào)：

規(guī)格：1 mg

貨期：

應(yīng)用：

咨詢客服

立即購買加入購物車

CAS:479543-46-9Formula:C19H12F4N4O2MW:404.32Appearance:WhitesoildPurity:99%byHPLC

商品詳情參考文獻(xiàn) 相關(guān)資料

A p38 MAP kinase inhibitor. VX-702 dose-dependently inhibited the production of IL-6, IL-1 and TNF (IC= 59, 122 and 99 ng/ml, respectively). Pre-incubation of platelets with VX-702 (1 M) completely or partially inhibited platelet agonist induced p38 activation (IC= 4 to 20 nM).

Additional Information

Synonyms	2-(2,4-Difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
Product #	V-2481
CAS #	479543-46-9
Chemical Name	2-(2,4-Difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide
Formula	C₁₉H₁₂F₄N₄O₂
MW	404.32
Appearance	White soild
Purity	99% by HPLC
Solubility	DMSO
Storage Temp	-20°C
Therapeutic Area	Inflammatory Diseases
Use	VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis

Additional Information

MDL Number	MFCD11616590
ChemACX	X1829255-4
InChI	InChI=1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29)
SMILES	C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F

熱銷產(chǎn)品